Literature DB >> 19783636

Reproductive and sphingolipid metabolic effects of fumonisin B(1) and its alkaline hydrolysis product in LM/Bc mice: hydrolyzed fumonisin B(1) did not cause neural tube defects.

Kenneth A Voss1, Ronald T Riley, Maurice E Snook, Janee Gelineau-van Waes.   

Abstract

Fumonisins are mycotoxins produced by Fusarium verticillioides. They are toxic to animals and exert their effects through mechanisms involving disruption of sphingolipid metabolism. Fumonisins are converted to their hydrolyzed analogs by alkaline cooking (nixtamalization). Both fumonisins and hydrolyzed fumonisins are found in nixtamalized foods such as tortillas, and consumption of tortillas has been implicated as a risk factor for neural tube defects (NTD). Fumonisin B(1) (FB(1)) induced NTD when given (ip) to pregnant LM/Bc mice; however, neither the NTD induction potential of hydrolyzed fumonisin B(1) (HFB(1)) nor its affect on sphingolipid metabolism in pregnant mice have been reported. The teratogenic potential of FB(1) and HFB(1) was therefore compared using the LM/Bc mouse model. Dams were dosed (ip) with 2.5, 5.0, 10, or 20 mg/kg (< or = 49 micromol/kg) body weight (bw) HFB(1) on embryonic day (E)7-E8. Negative and positive control groups were given vehicle or 10 mg/kg (14 micromol/kg) bw FB(1), respectively. The high dose of HFB(1) disrupted sphingolipid metabolism, albeit slightly, but did not cause maternal liver lesions or NTD (n = 8-10 litters per group). In contrast, 10 mg/kg bw FB(1) markedly disrupted maternal sphingolipid metabolism, caused hepatic apoptosis in the dams, increased fetal death rates, and decreased fetal weights. Furthermore, NTD were found in all FB(1)-exposed litters (n = 10), and 66 +/- 24% of the fetuses were affected. The findings indicate that HFB(1) does not cause NTD in the sensitive LM/Bc mouse model and only weakly disrupts sphingolipid metabolism at doses up to sevenfold higher (micromole per kilogram body weight basis) than the previously reported lowest observed adverse effect level for FB(1).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19783636     DOI: 10.1093/toxsci/kfp215

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  13 in total

1.  Distinct generation, pharmacology, and distribution of sphingosine 1-phosphate and dihydrosphingosine 1-phosphate in human neural progenitor cells.

Authors:  Phillip Callihan; Nicholas C Zitomer; Michael V Stoeling; Perry C Kennedy; Kevin R Lynch; Ronald T Riley; Shelley B Hooks
Journal:  Neuropharmacology       Date:  2011-10-15       Impact factor: 5.250

2.  The kinetics of urinary fumonisin B1 excretion in humans consuming maize-based diets.

Authors:  Ronald T Riley; Olga Torres; Jency L Showker; Nicholas C Zitomer; Jorge Matute; Kenneth A Voss; Janee Gelineau-van Waes; Joyce R Maddox; Simon G Gregory; Allison E Ashley-Koch
Journal:  Mol Nutr Food Res       Date:  2012-07-20       Impact factor: 5.914

3.  Production of fumonisins B2 and B4 in Tolypocladium species.

Authors:  Jesper Mølgaard Mogensen; Kirsten Amalie Møller; Pernille von Freiesleben; Roman Labuda; Elisabeth Varga; Michael Sulyok; Alena Kubátová; Ulf Thrane; Birgitte Andersen; Kristian Fog Nielsen
Journal:  J Ind Microbiol Biotechnol       Date:  2010-12-04       Impact factor: 3.346

4.  Modified hydra bioassay to evaluate the toxicity of multiple mycotoxins and predict the detoxification efficacy of a clay-based sorbent.

Authors:  K A Brown; T Mays; A Romoser; A Marroquin-Cardona; N J Mitchell; S E Elmore; T D Phillips
Journal:  J Appl Toxicol       Date:  2012-10-10       Impact factor: 3.446

5.  Enzyme characteristics of aminotransferase FumI of Sphingopyxis sp. MTA144 for deamination of hydrolyzed fumonisin B₁.

Authors:  Doris Hartinger; Heidi Schwartz; Christian Hametner; Gerd Schatzmayr; Dietmar Haltrich; Wulf-Dieter Moll
Journal:  Appl Microbiol Biotechnol       Date:  2011-04-19       Impact factor: 4.813

6.  In vivo formation of N-acyl-fumonisin B1.

Authors:  Henning Harrer; Hans Ulrich Humpf; Kenneth A Voss
Journal:  Mycotoxin Res       Date:  2014-10-19       Impact factor: 3.833

7.  Mitigation of Fumonisin Biomarkers by Green Tea Polyphenols in a High-Risk Population of Hepatocellular Carcinoma.

Authors:  Kathy S Xue; Lili Tang; Qingsong Cai; Ye Shen; Jianjia Su; Jia-Sheng Wang
Journal:  Sci Rep       Date:  2015-12-02       Impact factor: 4.379

Review 8.  Mycotoxins during the Processes of Nixtamalization and Tortilla Production.

Authors:  Sara Schaarschmidt; Carsten Fauhl-Hassek
Journal:  Toxins (Basel)       Date:  2019-04-16       Impact factor: 4.546

9.  Gastrointestinal Degradation of Fumonisin B₁ by Carboxylesterase FumD Prevents Fumonisin Induced Alteration of Sphingolipid Metabolism in Turkey and Swine.

Authors:  Sabine Masching; Karin Naehrer; Heidi-Elisabeth Schwartz-Zimmermann; Mihai Sărăndan; Simone Schaumberger; Ilse Dohnal; Veronika Nagl; Dian Schatzmayr
Journal:  Toxins (Basel)       Date:  2016-03-21       Impact factor: 4.546

10.  Enzymatic hydrolysis of fumonisins in the gastrointestinal tract of broiler chickens.

Authors:  B Grenier; H E Schwartz-Zimmermann; C Gruber-Dorninger; I Dohnal; M Aleschko; G Schatzmayr; W D Moll; T J Applegate
Journal:  Poult Sci       Date:  2017-12-01       Impact factor: 3.352

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.